Here is a recent article on Nader and Kazem. I don't remember reading that Kazem was on the Cytodyn committee for SEC reporting.

"Kazempour also served on CytoDyn’s Disclosure Committee, which was responsible for reviewing and approving CytoDyn’s periodic filings with the U.S. Securities and Exchange Commission."

https://insurancenewsnet.com/oarticle/two-bio...ry-affairs